Thanks­giv­ing edi­tion: Top 15 End­points sto­ries of 2021; Can you name that vac­cine?; Mer­ck­'s Covid an­tivi­ral dis­ap­points; FDA nom­i­nee's in­dus­try ties; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

Hap­py Thanks­giv­ing to all those who are cel­e­brat­ing it — al­though, if we are be­ing hon­est, this week’s ab­bre­vi­at­ed edi­tion is re­al­ly for those who are not. Wher­ev­er you’re tun­ing in from, we ap­pre­ci­ate your sup­port, hope you find this re­cap help­ful and we wish you a won­der­ful week­end.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.